BiotechTube
Home/SERB Pharmaceuticals/Dr. Peter C. Adamson
DP

Dr. Peter C. Adamson

Non-Executive Director (US Board)

SERB Pharmaceuticals

Roles

Non-Executive Director (US Board)atSERB Pharmaceuticals
Global Head of Oncology & Chief Development Officer, OncologyatSumitomo Pharma

Therapeutic Areas

Emergency MedicineOncologyRare Neurologic DiseasesRare Metabolic Disorders

SERB Pharmaceuticals Pipeline

DrugIndicationPhase
Antidote & CBRN PortfolioVarious poisonings and chemical/biological/radiological/nuclear threatsApproved
DANYELZA® (naxitamab)NeuroblastomaApproved
OMBLASTYS® (omburtamab)CNS/Leptomeningeal metastases from neuroblastomaApproved

Leadership Team at SERB Pharmaceuticals

DV
Dr. Vignesh Rajah
Chief Medical Officer
View full SERB Pharmaceuticals profile